For example, the upregulation of miR-20a and downregulation of miR-451 after the second cycle of neoadjuvant chemotherapy predicted resistance to treatment of hormone receptor-positive/HER2-negative BC patients [166]. The gene discussed is NR4A1; the disease is breast cancer.